$LLTP CEO Interview | Dr. Roger Crystal / Lightlake Therapeutics

Home » CEO Interviews » $LLTP CEO Interview | Dr. Roger Crystal / Lightlake Therapeutics

In this episode we will be talking to Dr. Roger Crystal, CEO of Lightlake Therapeutics.

Lightlake Therapeutics, ticker symbol LLTP, is a cutting edge biopharmaceutical company using its expertise in opioid antagonists to build a platform of innovative intranasal naloxone solutions to common addictions and related disorders.

Lightlake may be one of the most compelling investment ideas among small biotech companies, as it has traded completely under-the-radar while (1) inking a validating $55 Million partnership for its flagship intranasal naloxone product-candidate; (2) completing non-dilutive financing rounds at an implied valuation ~3X recent market prices; and (3) progressing its pipeline towards commercialization in numerous unmet multi-billion dollar markets.

They are a publicly traded company listed on the OTCQB under ticker symbol LLTP and you can find out more about them by visiting the company’s website at www.lighlaketherapeutics.com.

Get Alerts for Latest Featured Stocks!
Signup today and receive the newest videos. We will never share or sell your email address.
I agree to have my personal information transfered to MailChimp ( more information )
Author: Mike Elliott


Lost your password?